This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Novartis Ag, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015.
Company Filing History:
1 out of 3,974 
1 out of 3,690 
Years Active: 2015
Title: The Innovations of Rou-fun Kwong
Introduction
Rou-fun Kwong is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins. His work has implications for both cancer treatment and pathogen detection.
Latest Patents
Rou-fun Kwong holds a patent for "TEM8 antibodies, conjugates thereof, and their use." This patent describes antibodies that specifically bind to the TEM8 protein. The conjugates and antibodies outlined in the patent are useful for methods of detecting and treating pathogenic angiogenesis. Additionally, they can be employed in cancer detection and treatment, as well as in decreasing the binding of Anthrax protective antigen to cells.
Career Highlights
Throughout his career, Rou-fun Kwong has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the field of health sciences.
Collaborations
Rou-fun Kwong has collaborated with esteemed colleagues such as Brad St Croix and Tony Fleming. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Rou-fun Kwong's contributions to biotechnology, particularly through his patent on TEM8 antibodies, demonstrate his commitment to advancing medical science. His work continues to have a lasting impact on the detection and treatment of diseases.